Apollo Hospitals Enterprise Ltd. (APOLLOHOSP): Apollo Hospitals Share Price Hits Fresh 52-Week High

Apollo Hospitals Share Price hits a fresh 52-week high at Rs 9,099.95 with a market cap of Rs 1,28,423.42 Cr.

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) Share Price has reached a fresh 52-week high of Rs 9,099.95 today, marking a 0.18% increase from the previous close of Rs 8,986.40. The company's market capitalisation stands at Rs 1,28,423.42 crore. This milestone highlights the stock's strong performance in the healthcare sector, attracting investor attention despite the absence of a specific catalyst. The stock opened at Rs 9,099.95 and experienced a low of Rs 8,983.95, with a turnover of Rs 0.4 crore.

Apollo Hospitals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 9,002.95
Previous Close	Rs 8,986.4
Today's Change	+Rs 16.55 (+0.18%)
Day Open	Rs 9,099.95
Fresh 52-Week High	Rs 9,099.95
Day Low	Rs 8,983.95
Current Volume	446
Turnover	Rs 0.4 crore
Market Capitalisation	Rs 1,28,423.42 crore

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) traded at Rs 9,002.95. versus the previous close of Rs 8,986.4, a rise of 0.18%. The stock opened at Rs 9,099.95, reached Rs 9,099.95, touched Rs 8,983.95. Reported volume was 446.

Today, Apollo Hospitals Share Price opened at Rs 9,099.95, matching its fresh 52-week high, before settling at Rs 9,002.95. The stock's day low was Rs 8,983.95, and it closed with a modest gain of 0.18% from the previous day. The trading volume was 446 shares, indicating limited participation compared to its average. The turnover for the day was Rs 0.4 crore, reflecting the stock's stable demand in the market. This price action underscores the stock's resilience and investor interest, setting the stage for further analysis of its fundamentals.

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,28,423.42 crore
P/E Ratio	39.17x
P/B Ratio	7.93x
ROE	28.21%
ROCE	26.35%

Apollo Hospitals Enterprise Ltd. was valued at a P/E ratio of 39.17x, a P/B ratio of 7.93x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	39.17x
Benchmark Median P/E	20.13x
Benchmark Average P/E	73.73x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	7.93x
Benchmark Median P/B	1.92x
Company ROE	28.21%
Benchmark Median ROE	10.73%
Company ROCE	26.35%
Benchmark Median ROCE	13.2%
Company Market Capitalisation	Rs 1,28,423.42 crore
Benchmark Median Market Cap	Rs 140.91 crore

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) is classified under sector: Healthcare.

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a P/E ratio of 39.17x, which is above the benchmark median of 20.13x, a difference of +94.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a ROE of 28.21%, which is above the benchmark median of 10.73%, a difference of +162.91%. Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a ROCE of 26.35%, which is above the benchmark median of 13.2%, a difference of +99.62%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Kwality Pharmaceuticals Ltd.	KPL	2,700.98	39.17	7.93	28.21	26.35
Beta Drugs Ltd.	BETA	2,475.7	58.88	9.32	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,439.14	165.82	3.06	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,424.44	34.59	7	-2.6	16.92
Venus Remedies Ltd.	VENUSREM-BE	2,150.28	17.79	3.01	9.85	7.89

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a P/E ratio of 39.17x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) has a market capitalisation of Rs 1,28,423.42 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Apollo Hospitals

• Fresh 52-week high at Rs 9,099.95, indicating strong price momentum.
• High P/E and P/B ratios suggest premium valuation.
• Strong ROE and ROCE highlight superior profitability.
• Dominant market cap in the healthcare sector.

About Apollo Hospitals

Apollo Hospitals Enterprise Ltd. is a leading healthcare provider in India, operating a network of hospitals, clinics, and pharmacies. The company offers a comprehensive range of healthcare services, including specialty and super-specialty care, diagnostics, and telemedicine. With a strong focus on quality and innovation, Apollo Hospitals has established itself as a trusted name in the healthcare industry, catering to a diverse patient base across the country.

Track Apollo Hospitals Share Price on Univest

Use Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Apollo Hospitals Share Price, technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest. Stay informed about the latest developments and make data-driven investment decisions.

Frequently Asked Questions

What is the current share price of Apollo Hospitals?

Ans. The current share price of Apollo Hospitals is Rs 9,002.95, marking a fresh 52-week high of Rs 9,099.95 today. The stock moved 0.18% during the session. The intraday range extended from Rs 8,983.95 to Rs 9,099.95.

How does Apollo Hospitals' P/E ratio compare to the sector?

Ans. Apollo Hospitals' P/E ratio of 39.17 is above the healthcare sector median of 20.13, indicating a higher valuation compared to its peers. The company trades at a P/E ratio of 39.17x.

What is Apollo Hospitals' market capitalisation?

Ans. Apollo Hospitals' market capitalisation is Rs 1,28,423.42 crore, making it a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.17x. ROE is 28.21% and ROCE is 26.35%.

How does Apollo Hospitals' ROE compare to the sector?

Ans. Apollo Hospitals' ROE of 28.21% is significantly higher than the sector median of 10.73%, showcasing its strong profitability. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.

How does Apollo Hospitals' ROCE compare to the sector?

Ans. Apollo Hospitals' ROCE of 26.35% is well above the sector median of 13.2%, indicating efficient capital use. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.

Which peers are compared with Apollo Hospitals?

Ans. Peers compared with Apollo Hospitals include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., and Sai Parenteral's Ltd., among others. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd.

What is the P/B ratio of Apollo Hospitals?

Ans. Apollo Hospitals' P/B ratio is 7.93, which is higher than the healthcare sector median of 1.92, indicating a premium valuation. The company trades at a P/E ratio of 39.17x. Its P/B ratio is 7.93x.

How does Apollo Hospitals' market cap compare to the sector?

Ans. Apollo Hospitals' market cap of Rs 1,28,423.42 crore is significantly higher than the sector median of Rs 140.91 crore, underscoring its dominant position. The company operates in the Healthcare sector.